Stock TTT TRUTRACE TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials TruTrace Technologies Inc.

Equities

TTT

CA8984471075

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange
Other stock markets
 14:58:13 05/09/2023 BST 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for TruTrace Technologies Inc. -.--% -.--%
2023 TruTrace Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
2022 TruTrace Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022 CI

Valuation

Fiscal Period: April 2019 2020 2021 2022
Capitalization 1 21.66 6.669 14.51 3.817
Enterprise Value (EV) 1 20.49 6.899 13.61 4.498
P/E ratio -1.43 x -1.42 x -6.71 x -1.64 x
Yield - - - -
Capitalization / Revenue 2,165,518,300 x 16,561,425 x 89,267,132 x 32,224,751 x
EV / Revenue 2,049,196,400 x 17,131,758 x 83,773,009 x 37,973,468 x
EV / EBITDA -1,671,719 x -1,554,472 x -8,889,471 x -2,155,457 x
EV / FCF -5,172,362 x -21,541,225 x -9,916,623 x -5,654,992 x
FCF Yield -0% -0% -0% -0%
Price to Book 29.7 x -2.6 x -29.4 x -1.51 x
Nbr of stocks (in thousands) 80,204 83,362 152,694 152,694
Reference price 2 0.2700 0.0800 0.0950 0.0250
Announcement Date 23/08/19 13/10/20 26/08/21 29/08/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2018 2019 2020 2021 2022
Net sales - 0.01 0.4027 0.1625 0.1185
EBITDA - -12.26 -4.438 -1.531 -2.087
EBIT 1 -1.257 -12.26 -4.444 -1.536 -2.09
Operating Margin - -122,628.51% -1,103.54% -945% -1,764.37%
Earnings before Tax (EBT) 1 -1.267 -14.77 -4.639 -1.621 -2.335
Net income 1 -1.267 -14.77 -4.639 -1.621 -2.335
Net margin - -147,731.69% -1,152.08% -997.47% -1,970.71%
EPS 2 -0.0402 -0.1888 -0.0564 -0.0142 -0.0153
Free Cash Flow - -3.962 -0.3203 -1.373 -0.7955
FCF margin - -39,618.19% -79.53% -844.77% -671.5%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 13/06/19 23/08/19 13/10/20 26/08/21 29/08/22
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2018 2019 2020 2021 2022
Net Debt 1 - - 0.23 - 0.68
Net Cash position 1 0.03 1.16 - 0.89 -
Leverage (Debt/EBITDA) - - -0.0517 x - -0.3263 x
Free Cash Flow - -3.96 -0.32 -1.37 -0.8
ROE (net income / shareholders' equity) - -3,803% 504% 106% 155%
ROA (Net income/ Total Assets) - -1,004% -382% -126% -169%
Assets 1 - 1.471 1.214 1.282 1.382
Book Value Per Share 2 0 0.0100 -0.0300 -0 -0.0200
Cash Flow per Share 2 0 0.0100 0 0.0100 0
Capex - 0.03 - - -
Capex / Sales - 265.64% - - -
Announcement Date 13/06/19 23/08/19 13/10/20 26/08/21 29/08/22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Software & Technology Services

1st Jan change Capi.
TRUTRACE TECHNOLOGIES INC. Stock TruTrace Technologies Inc.
-.--% 559K
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+5.91% 32.95B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+20.47% 8.01B
SECTRA AB Stock Sectra AB
+33.03% 4.38B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-29.52% 2.67B
OMNICELL, INC. Stock Omnicell, Inc.
-13.29% 1.5B
VERADIGM INC. Stock Veradigm Inc.
-28.02% 1.27B
LUNIT INC. Stock Lunit Inc.
-33.09% 1.2B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+11.35% 996M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-38.47% 864M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. TTT Stock
  4. Financials TruTrace Technologies Inc.